Ulnar Deviation Arthritis: A Complete Patient Guide

Overview

Ulnar deviation arthritis (also called *ulnar drift* or *ulnar deviated rheumatoid arthritis*) is a pattern of joint damage in which the fingers, particularly the metacarpophalangeal (MCP) joints, drift toward the ulnar (little‑finger) side of the hand. While the term can describe changes seen in several types of inflammatory arthritis, it is most commonly associated with rheumatoid arthritis (RA). The condition leads to pain, swelling, and loss of hand function.

Who it affects: Adults with longstanding inflammatory arthritis are at highest risk. Women are affected roughly twice as often as men, reflecting the gender distribution of RA. The average age of onset of ulnar deviation is 45‑65 years, but it can appear earlier in aggressive disease.

Prevalence: Approximately 25‑30 % of patients with established rheumatoid arthritis develop clinically evident ulnar deviation of the MCP joints within 10 years of diagnosis (source: NIH – Arthritis Rheum 2009). Because many cases are mild, radiographic studies suggest the true prevalence may be as high as 40 %.

Symptoms

Symptoms evolve slowly and may be intermittent at first. Below is a complete list with brief explanations.

• Joint pain or aching – usually worse with use and improves with rest.
• Swelling (synovitis) – soft tissue puffiness around the MCP joints.
• Ulnar drift of fingers – the fingers angle toward the little finger side; most noticeable in the index and middle fingers.
• Stiffness – especially in the morning or after inactivity; may last >30 minutes.
• Reduced grip strength – difficulty holding objects, turning knobs, or opening jars.
• Joint deformities – Boutonnière or swan‑neck deformities may accompany ulnar deviation.
• Clicking or popping sensations – due to subluxation of the joint surfaces.
• Loss of fine motor dexterity – trouble with tasks like typing, buttoning shirts, or playing a musical instrument.
• Visible skin changes – redness, warmth, or occasional bruising from minor trauma.

Causes and Risk Factors

Underlying Pathophysiology

Ulnar deviation results from chronic inflammation of the synovial membrane (synovitis) that erodes cartilage and destabilizes the collateral ligaments on the radial side of the MCP joints. As the radial (thumb‑side) structures weaken, the unopposed pull of the ulnar side causes the fingers to drift.

Primary Causes

• Rheumatoid arthritis (RA) – the leading cause; the autoimmune attack targets the same joints.
• Psoriatic arthritis – less common but can produce a similar pattern.
• Systemic lupus erythematosus (SLE) and other connective‑tissue diseases.
• Traumatic injury – repeated micro‑trauma to the MCP joints may accelerate deviation in susceptible individuals.

Risk Factors

• Long‑standing, uncontrolled inflammatory arthritis.
• Female gender (higher RA prevalence).
• Smoking – worsens RA severity and joint damage.
• Genetic predisposition (HLA‑DRB1 shared epitope).
• Obesity – adds mechanical stress to hand joints.
• Delayed diagnosis or inadequate disease‑modifying therapy.

Diagnosis

Diagnosis combines clinical assessment, imaging, and laboratory tests to confirm the underlying arthritis and to stage the degree of ulnar deviation.

History & Physical Examination

• Detailed symptom timeline (onset, duration, triggers).
• Assessment of hand function – grip strength, pinch, range of motion.
• Visual inspection for drift, swelling, deformities.
• Special tests:
  • Stress testing of MCP ligaments.
  • Finkelstein’s or ulnar deviation stress test to reproduce pain.

Imaging

• X‑ray – first‑line; shows joint space narrowing, erosions, and the angle of drift.
• Ultrasound – detects active synovitis and can guide steroid injections.
• MRI – provides detailed view of cartilage loss and soft‑tissue inflammation when diagnosis is uncertain.

Laboratory Tests

• Rheumatoid factor (RF) and anti‑CCP antibodies – positive in >70 % of RA patients.
• Inflammatory markers – ESR and CRP to gauge disease activity.
• Complete blood count (CBC) – looks for anemia of chronic disease.
• Joint fluid analysis – rarely needed but helps rule out infection.

Treatment Options

Treatment aims to control inflammation, halt further joint damage, and restore hand function. A multidisciplinary approach—rheumatology, hand surgery, physical therapy, and occupational therapy—is often most effective.

Medications

• Non‑steroidal anti‑inflammatory drugs (NSAIDs) – relieve pain and swelling (e.g., ibuprofen, naproxen). Use cautiously in patients with GI, renal, or cardiovascular disease.
• Glucocorticoids – short‑term oral prednisone or intra‑articular corticosteroid injections for acute flares.
• Disease‑modifying antirheumatic drugs (DMARDs)**
  • Conventional DMARDs: methotrexate (first‑line), sulfasalazine, hydroxychloroquine.
  • Biologic DMARDs: TNF inhibitors (etanercept, adalimumab), IL‑6 blockers (tocilizumab), abatacept, rituximab.
  • Targeted synthetic DMARDs: Janus kinase (JAK) inhibitors (tofacitinib, upadacitinib).

  Early and aggressive DMARD therapy is the most effective way to prevent or slow ulnar deviation (source: Mayo Clinic).